
This Update consists of five modules covering new and changing knowledge on:


This Update consists of five modules covering new and changing knowledge on:


This Update includes modules covering new and changing knowledge on:
Please note: The following EKU2019.2 modules have been archived as the content is now out of date and no longer reflects current best practice:


This Update includes a module covering new and changing knowledge on:
Please note: The following EKU2018.2 modules have been archived as the content is now out of date and no longer reflects current best practice:


This Update includes a modules covering new and changing knowledge on:
Please note: The following EKU2017.3 modules have been archived as the content is now out of date and no longer reflects current best practice:


This Challenge provides a twenty item online applied knowledge test with instant answer access. The questions included within the Challenge are sourced from the content of the modules and reference material found within EKU2022.2.

|
|
Essential Knowledge Challenge 2019.2 provides an online applied knowledge test with instant answer access. The questions included within the Challenge are sourced from the content of the modules and reference material found within EKU2019.2 as well as the EKU Journal Watch and Hot Topics released during September to December 2018. |


This course consists of two 30-minute modules and a 15-minute podcast on the subject of prescribing safety. The first module provides context and background to the issue of prescribing safety and the progress so far. This sets the scene for the second module, where approaches to improving prescribing safety are discussed, and practical tips for the implementation of strategies to promote safe prescribing are shared.
The podcast expands on some of the key points from the modules. In addition, other aspects of good quality prescribing and strategies to minimise errors are explored by the sharing of learning experiences.
Financial support for this programme was provided from Pfizer Limited. Editorial and content decisions were made solely by the RCGP.

